This year CPHI Europe opens its doors in Milan at Fiera Milano. From 6th to 8th October you can have a face-to-face chat with visitors and exhibitors again. As usual, InnoPack, P-MEC, FDF, ICSE, MedTech and BioProduction will be held together with CPHI.
Pharma Excipients gives you an overview of the excipient suppliers, their booths, main topics and products in the following:
You can find the excipient manufacturers this year
mainly in hall 1.
As one of the world’s largest nutrition companies, ADM offers highly purified oils derived from vegetable origins and carbohydrate solutions that meet relevant pharmaceutical regulations and are manufactured according to GMP and cGMP standards, as well as a full range of science-backed pre-, pro- and postbiotics, functional botanicals, plant sterols, Vitamin E, and more for dietary supplements.
ARMOR PHARMA is thrilled to announce their presence at CPHI Milan. Their team of experts is ready to welcome you and answer all your questions at booth 1F34, Hall H01.
ARMOR PHARMA manufactures and markets 3 ranges of pharmaceutical grade lactose for all your applications. From Oral Solid Dosage Forms to Dry powder Inhalers, find the suitable lactose for your target formulation:
ARMOR PHARMA™: Sieved & Milled lactose for sachets, capsules and tablets formulation
EXCIPRESS™: Granulated and Spray-dried lactose for Direct Compression
EXCIPURE™: coarse and fine lactose grades for Dry powder Inhalation
The ARMOR PHARMA team looks forward to discussing projects and sharing solutions with you !
For any inquiries before the event, feel free to contact them at [email protected].
Ashland is a global additives and specialty ingredients company with a conscious and proactive mindset for environmental, social and governance (ESG). The company serves customers in a wide range of consumer and industrial markets, including architectural coatings, construction, energy, food and beverage, personal care and pharmaceutical. Ashland offers a broad selection of high quality excipients to formulate effective pharmaceutical products. Their growing portfolio supports your developments in oral and liquid dosage applications, film coatings, long-acting injectables, medical devices and oral biologics. Contact us to discuss your project.
Ashland´s focus topics at CPhI Milan 2026:
Oral biologics
permexa™ sodium caprate (see visual attached) – newest addition to our portfolio, permexa™ sodium caprate is a permeation enhancer designed to support oral absorption of poorly permeable molecules, including peptides and biologics
plasdone™ s-630/s-630 ultra copovidone – for solubilization and stabilization
Highly purified sugars for stabilization
vialose™ trehalose dihydrate, vialose™ sucrose and new vialose™ mannitol – our vialose™ range of highly purified sugars now includes a new addition (vialose™ mannitol). These excipients are commonly found in biological medicines and used as protein stabilizers and lyoprotectants.
Asahi Kasei is the leading manufacturer and supplier of functional excipients such as microcrystalline cellulose (MCC) in Japan. They leveraged five decades of experience and our proprietary morphology design technology to create high-performance MCC products with unique properties.
With their superior flowability and compactibility, their CEOLUS™ high functional grades bring formulation design and tabletting efficiency to a new level, particularly for high dose, small tablet, and low-compactibility drug formulations. CELPHERE™, the MCC spherical cores allow the combination of incompatible APIs in one tablet, achieve robust release profile and improve the acceptability of products. The pregelatinized starch PC-10 can be applied for protection of moisture sensitive APIs.
BENEO’s excipient galenIQ™ is a range of water-soluble filler-binders. Derived from beet sugar it has a sweet taste and promotes a pleasant, well-balanced gustatory profile in pharmaceutical formulations. Due to these unique sensorial properties it is an optimal choice for solid and liquid oral applications, and especially those in combination with active ingredients or plant extracts which have a bitter and / or unpleasant flavour.
At CPHI Milan 2026, BENEO is putting sachets in the spotlight.galenIQ™ 721 combines excellent flowability and low fines content for precise filling, low-dust processing and reliable sealing, while its sweet taste supports a pleasant patient experience. Visit the BENEO team to explore new sachet concepts, discuss your development challenges and celebrate 20 years of galenIQ™ with them.
BIOGRUND is specialized in homogeneous mixing of excipients and carriers in the dietary supplement and pharmaceutical industry. The tailor-made and ready-to-use excipient premixes for film coatings, sugar-coatings, colorings and tableting enable optimum results in a short time. Film coating systems for fast/sustained release and enteric protection. Furthermore, premixed tableting excipients like binders, lubricants and flow aids deliver new possibilities to improve your production processes.
Biogrund is looking for agents/distributors in: Canada, Mexico, Brasil and Argentina.
Biogrund at CPhI Milan
📍 Booth: 1B73, zone Excipients & Fine Chemicals
CarboHyde
CarboHyde is a global leader in cyclodextrin science, offering end-to-end expertise in custom cyclodextrin synthesis, analytical characterization, formulation development, and IP support. They also supply a broad portfolio of both standard and unique cyclodextrins and are expanding into ready-to-use cyclodextrin–active complexes for food supplements and cosmetic applications. From molecule design to commercial product development, CarboHyde helps partners unlock the full potential of cyclodextrin technology.
In today’s world medical innovations and pharmaceutical technology are essential drivers of human health. Every single day, millions of health and personal care products are being manufactured, packaged, stored, or shipped to healthcare facilities, distributors, or to points of retail sale worldwide.
These products are contained in bulk cartons, bottles, or bagged powder packages, Clariant Cargo & Device Protection offers desiccant solutions – Sorb-It silica gel, Desi Pak bentonite clay, and Tri-Sorb molecular sieve – to adsorb moisture and help preserve product efficacy.
Croda Pharma is a leading partner for the development of excipients and the supply of high-purity materials for pharmaceutical formulations.
This year at CPHI Europe, they’re bringing the refreshed Croda Pharma brand to life.
Join them at Booth 1B94 to discover our latest innovations and connect with the people shaping the future of pharmaceutical excipients and drug delivery.
Croda Pharma at CPhI 2026 Milan
EXPERIENCE. EXPLORE. CONNECT.
Experience their refreshed brand
See how Croda Pharma’s new identity reflects tehir commitment to innovation, partnership, and helping our customers solve today’s formulation challenges while preparing for tomorrow’s opportunities.
Explore their interactive demonstration area
Get hands on with their technologies through live demonstrations that showcase our expertise, capabilities, and the science behind our solutions.
Connect with their experts
The commercial and technical teams will be on hand throughout the week to discuss your challenges, answer your questions, and explore how they can support your next pharmaceutical innovation.
Whether you’re developing biologics, small molecules, vaccines, or advanced therapies, they’d love to talk.
Visit Croda Pharma at CPHI Europe and experience their new brand in action.
DFE Pharma is a global leader in excipient solutions. They empower pharmaceutical companies to develop and manufacture drug products with speed and confidence, by combining the purest excipients with supply security, technical expertise, and a commitment to sustainability. Their high-quality functional excipients are used in the pharmaceutical, biopharmaceutical, and nutraceutical industries for OSD, respiratory, ophthalmic and parenteral formulations.
From processing to formulation, to packaging – Dow has you covered. With global breadth, scale, and asset integration as well as decades of experience in regulated products, Dow’s pharmaceutical portfolio allows you to manufacture, formulate and package your pharma products with confidence. Learn more about their best-in-class performance, quality and supply reliability for your needs in:
API Laxatives
Pharmaceutical-Grade Excipients for RX & OTC
API Manufacturing Aids
Pharmaceutical & Medical Packaging
Request a meeting with a Dow representative at CPHI to discuss your challenges, explore opportunities and discover how Dow can support your next innovation.
Visit Dr. Paul Lohmann® at CPHI Milan in hall 1 | booth 1A114 and discover the latest solutions for the pharmaceutical, biopharmaceutical and biotech industries.
One of their key highlights is amino acid salts for biopharmaceutical applications. The highly soluble DPL-BioPharm amino acid salts are designed to support demanding biopharmaceutical processes – from optimized cell culture media and enhanced cell performance to efficient and reliable production processes.
Another key focus is the portfolio of iron & magnesium salts as active pharmaceutical ingredients (APIs). With high-purity iron and magnesium salts, they support the development and production of advanced pharmaceutical formulations while meeting stringent quality and regulatory requirements.
Why visit Dr. Paul Lohmann® at CPHI Milan?
They offer more than just the product. They combine high-quality mineral salts with comprehensive service, application-specific expertise and reliable documentation. At the same time, they respond flexibly to individual customer requirements – from customized specifications and defined quality parameters to tailored product and supply solutions. This enables them to support their customers throughout their projects with quality, expertise, documentation, and service from a single source.
Meet the Dr. Paull Lohmann team at CPHI Milan 2026 – hall 1 | booth 1A114. Talk with them about your specific requirements and discover how they can develop the right solution for your application.
Meet Evonik at CPHI Milan 2026!
From October 6-8, Evonik Health Care will be at CPHI Milan showcasing solutions that support pharmaceutical innovation across drug substance manufacturing, drug delivery, and biopharma applications.
They’re looking forward to connecting with customers, partners, and innovators from around the world to discuss the challenges and opportunities shaping the future of health care . Visit them at Booth A49, Hall 12
Join also the Evonik Lunch & Learn event on parenteral drug delivery before CPHI Milan!
From bioabsorbable polymers to lipid nanoparticles, the landscape of parenteral drug delivery is evolving rapidly. But what technologies are shaping the next generation of injectable therapies, and what opportunities do they create for drug developers?
Evonik invites you to their Lunch & Learn event: Parenteral Possibilities: From Polymers to Lipid Nanoparticles
📍 Milan, Italy
📅 October 5, 2026
This event will bring together experts and pharmaceutical innovators to explore key trends and technologies in parenteral drug delivery, including advanced excipients, lipid-based delivery systems, and emerging approaches for complex therapeutics. Whether you’re developing long-acting injectables, nucleic acid therapies, biologics, or other advanced drug products, this is an opportunity to gain insights, exchange ideas, and connect with peers before CPHI Milan.
Seats are limited, so register early to secure your place.
📍 Booth: 12A49, zone Contract Manufacturing & Services
Fuji Chemical Industries Co., Ltd. is a leading manufacturer of Active Pharmaceutical Ingredients, Drug Products, Excipients, and Natural Astaxanthin. Their specialized contract manufacturing services include API synthesis, solid dispersion development with advanced spray drying technology, and more.
In addition, they provide unique and highly functional excipients for oral dosage forms, such as Neusilin®, Fujicalin®, and F-MELT®, which are widely recognized for improving stability, compressibility, and dissolution performance. With a strong commitment to innovation, quality, and reliability, Fuji Chemical continues to support pharmaceutical and nutraceutical partners worldwide in creating effective, safe, and high-performing products.
Your contact: Dr. Rohit Pawar, Senior Manager – Technical Services and Business Development, [email protected]
Gangwal Healthcare – a solutions provider for Complex, Innovative & Cutting-edge technological formulations!
Gangwal Healthcare is an efficacious solution provider and manufacturer that combines innovative research with smart, seamless technology to address the complex challenges of the healthcare system through novel formulations that enhance quality of life.
Today, as newer health challenges continue to emerge, Gangwal Healthcare strives to resolve them by leveraging its rich knowledge base and working alongside industry experts, research partners, and customers. With a focus on innovation, reliability, and patient-centric solutions, the company is committed to developing advanced formulations that meet evolving global healthcare needs and set new benchmarks in performance and safety.
Since 1880, Gattefossé has provided high-quality lipid excipients for human and animal health. Our oral excipients enhance solubility, bioavailability, release, lubrication, and taste-masking. We offer solubilizers, emulsifiers, penetration and viscosity enhancers for topical route, plus bases for suppositories and pessaries for rectal and vaginal routes. Backed by full regulatory support, our experts assist globally via Technical Centers in France, China, India, and the U.S.
This year, Gattefossé is proud to present its new solid surfactants range, for optimal use of lipid-based excipients in oral solid dosage forms. Come join them at their booth to learn more!
If you want to book an appointment: Margaux Saletes, [email protected]
Gattefosse at CPhI 2026 Milan
📍 Booth: 1D66, zone Excipients & Fine Chemicals
Grace
Grace is a global leader in custom-engineered silica solutions for the pharmaceutical industry. Their portfolio of multifunctional excipients, including SYLOID® mesoporous silica, helps formulators improve stability, flowability, moisture control, and active ingredient delivery.
Connect with the Grace team at CPHI Milan to discover how we can help advance your next formulation – stop by stand 10F5 in the Contract Manufacturing zone.
Indovinya is the global specialty chemical and surfactants division of Indorama Ventures, with operations across 10 countries and 15 manufacturing locations. We are the No. 1 producer of nonionic surfactants and ethylene oxide in the Americas, and the No. 2 ethoxylation company globally. Leveraging the chemical expertise of Indovinya’s specialists, we offer a reliable portfolio of multi-compendial excipients designed to deliver consistent performance and meet the most stringent regulatory requirements of the global pharmaceutical industry.
📍 Booth: 1H10, zone Excipients & Fine Chemicals
ingredientpharm, Glatt Pharmaceutical Services and Glatt Group
ingredientpharm specializes in niche pharmaceutical excipients that enable controlled release and taste masking in solid dosage forms. Their portfolio includes innovative starter pellets such as CELLETS® (microcrystalline cellulose cores) and TAP® (tartaric acid cores), which serve as excipient substrates in advanced multiparticulate drug delivery systems.
Find ingredientpharm and Glatt Pharmaceutical Services at the booth of the Glatt Group 9C24.
The Glatt Group has been involved in powder technology for over 70 years and has become renowned as one of the world’s major manufacturers in fluid beds for the pharmaceutical industries, specialising in techniques for solid product forms for the food, feed, pharmaceutical and fine chemical industries.Besides pilot and production equipment for both batch and continuous processing Glatt has further extended to a wide range of processing lines, offering product and process development, contract manufacturing, plant design and engineering services.
At IOI Oleo GmbH, we leverage more than a century of lipid expertise to provide pharmaceutical excipients that support bioavailability enhancement, lipid-based drug delivery, controlled release and patient-centric dosage forms. Produced in Germany under stringent GMP and quality standards, our excipient portfolio is trusted by pharmaceutical developers worldwide.
LipoGalen® was born out of a deep understanding of the evolving challenges in pharmaceutical formulation. In contrast to common triglycerides, it crystallizes in one stable modification and does not show any polymorphism.
LipoGalen® offers a versatile, forward-thinking platform designed to empower innovation across a wide range of applications:
Rectal and vaginal dosage forms: A novel lipid base that offers new possibilities in the formulation development of such products, with advantages for patients.
Controlled-release tablets: Matrix systems that allow precise control over drug-release profiles throughout the shelf-life, because of the superior properties of LipoGalen® over traditional triglycerides.
Solubilization and bioavailability enhancement: Perfect for hot melt extrusion, improving the performance of poorly soluble APIs, while offering the chance of working at reduced processing temperatures compared to the established polymers in this field of application.
Taste masking: Effective via hot melt coating, helping improve patient compliance.
Lubrication for tableting: Optimized for continuous manufacturing processes.
Dermal formulations: Free from paraffins, supporting clean-label, skin-friendly solutions.
Advanced delivery systems: Suitable for lipid nanoparticles and nano-emulsions, including inhalation therapies.
3D-printing: Compatible with melt extrusion techniques for personalized medicine and cutting-edge dosage forms.
JRS Pharma is a leading manufacturer of excipients, offering a complete portfolio of solutions for the global pharmaceutical and nutraceutical industries. Our excipient portfolio includes high-functionality excipients, binders, disintegrants, lubricants, functional fillers, thickeners, stabilizers, gelling agents, carriers, and coatings.
In addition to our broad excipient range, JRS Pharma provides tailor-made formulation solutions and technical expertise to support customers in overcoming complex development and manufacturing challenges. With a strong commitment to quality, innovation, and partnership, we help advance reliable and effective drug delivery worldwide.
KLK OLEO Life Sciences is a leading manufacturer of high-quality pharmaceutical excipients, offering a broad portfolio of products such as Glycerine, MCT, Triacetin, Macrogols (PEG), Polysorbates, and Sorbitan Esters.
At CPhI 2026 Milan, KLK OLEO Life Science will highlight its position as a manufacturer of high-quality pharmaceutical excipients produced under GMP EXCiPACT standards. The company will showcase its ENHEX and Hedjuvan excipient portfolios while introducing several new product developments.
Highlights at CPhI 2026:
Showcasing the ENHEX (Glycerin, MCT, Triacetin) and Hedjuvan (Polysorbates, Macrogols/PEGs, Sorbitan Esters, Macrogol Lauryl Ether) excipient portfolios manufactured under GMP EXCiPACT.
Launching our new excipients including Macrogol Cetostearyl Ether and Macrogol Stearate, as well as PEG 3350and PEG 4000, now also available in powder form.
Featuring ENHEX G 86 XPS, a high-purity glycerin grade and our alternative for synthetic glycerol.
Presenting Davos Life Tocotrienol as part of its specialty offering.
Highlighting the Hedjuvan Circular Grade portfolio, enabling customers to reduce their environmental footprint through excipients with a significantly lower Product Carbon Footprint (PCF).
Lactalis Ingredients Pharma at CPHI Milan 2026: Lactalpha, a range of pharmaceutical lactose, from 50 to 200 mesh size, dedicated for oral solid dosage forms.
At Lactalis Ingredients pharma, we believe that expertise, quality, and sustainability are essential for long-lasting partnerships. With more than 50 years of know-how in lactose production, the Lactalpha range represents trust, quality, and reliability while committed to strong environmental engagement to ensure a sustainable supply in the coming years, through carbon footprint reduction, water conservation, and energy-efficient processes. Join us to learn more about our solutions.
Produced in France in a EXCiPACT-certified facility
Internal resource of raw liquid whey from Lactalis Group
Lactalpha: a range of pharmaceutical lactose, from 50 to 200 mesh size, dedicated for oral solid dosage forms with low nitrites guarantees (≤ 0.1 ppm)
Lipoid, a German-based company, is the world’s only supplier producing a fully comprehensive range of natural, hydrogenated, and synthetic phospholipids for pharmaceutical applications in GMP quality on an industrial scale. The globally present Lipoid Group employs some 500 people at its production sites and numerous distribution centers. Phospholipids provide the essential basis for innovative parenteral (e.g., liposomes, emulsions, mixed micelles, lipid nanoparticles, injectable depots), oral, pulmonary, ocular and topical drug products.
Visit Capsugel at Zone Excipients, Hall 1, Stand A2. As a trusted partner to the pharmaceutical and nutraceutical industry, we deliver high-quality Capsugel® capsules, advanced drug delivery technologies, and formulation expertise. Our portfolio also includes science-backed nutraceutical ingredients, enabling tailored solutions across pharma and health nutrition applications.
Lubrizol will showcase its portfolio of multifunctional excipients at CPHI Milan (6-8 October), and demonstrate how they solve diverse drug delivery challenges.
Visitors to stand 1F40 (in the Excipients & Fine Chemicals Zone) will be able to explore the benefits of Lubrizol’s pharmaceutical excipient technologies. These include improvements to formulation performance, the patient experience, and product differentiation across a wide range of dosage forms, including:
Apisolex™ pharmaceutical excipient for injectable oral dosage forms – a novel, polyamino acid-based polymer excipient with a micelle-formulation mechanism. It enhances API solubility up to 50,000-fold, supports high drug loading of up to 40%, and allows simple formulation techniques. Based on sarcosine, a non-toxic, biologically inert, and biodegradable amino acid, it has the potential to lower dosage frequency and/or duration, for more manageable, patient-friendly drug delivery
Apinovex™ pharmaceutical excipient for oral dosage forms – a novel, high molecular weight polymer excipient compatible with a wide range of BCS Class II and Class IV APIs. Its formulation benefits include up to 10-fold improvement in the dissolution of crystalline APIs and high drug loading of up to 80% via spray drying. This enables smaller capsule and tablet sizes that are more acceptable to patients
Carbopol® pharmaceutical excipients for oral and topical dosage forms – polymer excipients widely used in controlled release, bioadhesion, topical delivery, and formulation stabilization. Their benefits include excellent physical properties for tablet hardness and lower friability, high drug loading, and taste masking, enabling more palatable oral formulations. They also offer enhanced texture and stability for creams, lotions, and gels
MAGNESIA GmbH has been a supplier of high-quality mineral compounds for over 40 years and is internationally known for its high service orientation, product quality and level of innovation. MAGNESIA supplies customers of the pharmaceutical, cosmetics, nutritional supplements and food industries as well as manufacturers of technical applications. We offer a unique range of mineral compounds based on magnesium, calcium, sodium, potassium, iron and zinc which can be used as excipients or active pharmaceutical ingredients.
Medelpharm is an international engineering company that specializes in manufacturing high-precision research and development tableting instruments and powder processing equipment. The company develops advanced compaction simulator technology used in the pharmaceutical, chemical, and food industries to solve complex formulation challenges.
For excipient suppliers: STYL’ONE Compaction Simulator & R&D Tablet Press to develop new grades of DC excipients, demonstrate performances of DC excipients, benchmark again competition, provide technical support to excipient suppliers’ customers
For CDMOs, CROs, CMOs: STYL’ONE Compaction Simulator & R&D Tablet Press to acquire flexibility to develop new drugs, support scale-up to production, troubleshoot production issues, validate the processability of the blend before quoting a project
Preferred contact details for anyone that would like to reach you before the show to book an appointment
MEGGLE is an expert in pharmaceutical excipients, combining more than 70 years of experience with high product quality, application expertise and continuous innovation.With a broad portfolio ranging from excipients for wet granulation and capsule filling to advanced solutions for direct compression and dry powder inhalation, MEGGLE supports pharmaceutical manufacturers throughout formulation development.
At CPHI Milan 2026, MEGGLE will showcase its latest developments in pharmaceutical excipients, application expertise and digital support tools available through ZoomLab®.
ZoomLab® – Digital Application Services: Explore MEGGLE’s growing portfolio of digital formulation tools. With DirectCost now being part of ZoomLab®, pharmaceutical formulations and manufacturing processes can be compared based on production costs, process times and key cost drivers – helping formulators evaluate alternatives and make more informed development decisions ( https://www.meggle-excipients.com/direct-cost-production-cost-calculation ).
Nitrosamine Risk Assessment Calculator: A science-based digital tool supporting the initial assessment of potential nitrosamine formation risk. It helps users evaluate acceptable nitrite limits and explore formulation optimization strategies (https://www.meggle-excipients.com/2026/07/09/meggle-low-nitrite-grades ).
DPI Lactose Blend Prediction Tool: Supporting data-driven DPI formulation development by enabling users to assess lactose blend characteristics and compare different fine and coarse lactose combinations ( https://www.meggle-excipients.com/blend-prediction-tool ).
Discover how MEGGLE combines pharmaceutical excipients, formulation expertise and digital solutions to support more efficient and informed formulation development.
Visit MEGGLE at CPHI Milan 2026 in Hall 1, Booth 1A50, Excipients Zone.
Mingtai Chemical Co Ltd has more than 50 years experience in the Excipient industry. Its commitment to Product Quality & Service and environmental sustainability are the key components carry on the business successfully. The development stretched from its core business Microcrystalline Cellulose/Silicified Microcrystalline Cellulose(Comprecel), Croscarmellose Sodium (Disolcel) and Microcrystalline Cellulose Colloidal Grade (Neocel) into variety fulfills global market. Furthermore, CEP and FDA DMF registered for markets which have such concern.
Their main products shown at CPHI this year:
Comprecel®– Microcrystalline Cellulose A nature-derived binder and filler
Comprecel® SMCC – Silicified Microcrystalline Cellulose A co-processed binder and filler with minimal sensitivity to lubricants
Disolcel® – Croscarmellose Sodium A super disintegrant effective at low inclusion levels
Neocel®– Microcrystalline Cellulose and Carboxymethylcellulose Sodium A versatile suspending agent and emulsion stabilizer
Nordic Bioproducts develops high-purity, sustainably produced microcrystalline cellulose (MCC) using its patented AaltoCell™ technology, transforming locally sourced Finnish wood into pharmaceutical-grade excipients with a strong focus on quality, safety, and environmental performance. At CPHI Milan 2026, the company will showcase its PURA Series™ MCC portfolio, highlighting how its innovative production process combines exceptional purity with reliable European supply and a significantly lower environmental footprint.
Highlights at CPHI Milan 2026
Showcasing the PURA Series™ portfolio of pharmaceutical-grade microcrystalline cellulose (MCC).
Produced using the patented AaltoCell™ continuous manufacturing technology with locally sourced Finnish wood and 100% green energy.
Delivers exceptional purity, including nitrite below detection level and negligible black spots for enhanced product quality and consistency.
Manufactured in Europe with a secured European supply chain and a low-carbon, sustainable production process.
Produced under Excipient GMP, ISO 9001:2015, and EXCiPACT certification, meeting major pharmacopoeia standards for pharmaceutical applications.
Established in 1832, Japan-based trading house having manufacturing companies of Nagase Viita Co., Ltd.
The world largest commercial manufacturer of saccharide-base excipients have launched SOLBIOTE portfolio including high-purity and low-endotoxin TREHALOSE SG and MALTOSE PH, providing solutions for biologics, vaccine, and cell-based therapeutics developent. We also offer raw materials for nucleotide production, support large and commercial GMP oligonucleotide/Peptide APIs production.
PMC Isochem offers custom manufacturing and catalogue products for Pharmaceutical companies worldwide. Our offer addresses:
CDMO services: GMP industrial exclusive custom synthesis from development to production, including route selection. 3 FDA audited manufacturing plants. Drug delivery solutions: TPGS-1000 NF USP for poorly soluble drug formulation and Polypeptides based solution for Nano Encapsulation and Polymer Drug Conjugates Generic. APIs: 15 generic API for worldwide marketBuilding Blocks, NCA, Intermediates
PQ offers high-quality, innovative silica for pharmaceutical applications. Our portfolio of silica excipients supports applications from API moisture protection and anti-caking to value-adding MADG processing. With more than 200 years of collaborative innovation, PQ partners with industry leaders to deliver high-quality, safe, and reliable solutions.
Roquette’s comprehensive portfolio spans excipients, hard capsules, vegan soft capsules, active ingredients, biopharma technologies, and advanced drug delivery systems. We support a wide range of formulation needs including controlled release, immediate release, solubility and stability enhancement, and nitrosamine mitigation strategies – all backed by world-class technical expertise and a strong commitment to manufacturing excellence, regulatory compliance, and Quality by Design (QbD) principles.
Seppic, an Air Liquide Healthcare company, has been a leader in the pharmaceutical excipients industry for over 80 years. The company develops, manufactures, and markets unique excipients and specialty ingredients to advance human and veterinary health worldwide. An expert in surfactants, polymers, and formulation, Seppic offers solutions for oral, topical, and parenteral routes of administration. Its portfolio includes film-coating agents, powdered solubilizers for tablets, as well as injectable solubilizers and polymers for dermo-pharmaceuticals. Seppic also provides high-performance adjuvants for therapeutic and prophylactic vaccines.
Shin-Etsu, a global leader in specialty chemicals, is a trusted partner to the pharmaceutical industry, supplying high-quality cellulose ether excipients such as Metolose®, Pharmacoat®, and Tylopur®, L-HPC, MC, HPMC, and Shin-Etsu AQOAT®. With more than 50 years of expertise, the group supports drug development across oral solids, coatings, sustained release, disintegrants, and liquid formulations, while continuing to invest in expanded production capacity in Europe and Japan to ensure innovation and reliable supply.
Sigachi is a leading manufacturer and exporter of pharmaceutical excipients with over 30 years of expertise and three multilocational manufacturing facilities. Recognized globally as one of the top producers of Microcrystalline Cellulose and other excipients, Sigachi operates facilities certified by EXCiPACT GMP, SGMP, HACCP, ISO 9001:2015, and holds CEP (EDQM) for MCC. Our products are backed by US DMF, and our SEZ facility in Dahej, Gujarat is built to USFDA and EDQM standards, ensuring consistent quality and global compliance.
Join SPI Pharma and ABITEC at CPHI Milan Booth # 1D18
This year, CPHI Milan will be an exciting milestone for SPI Pharma. As our company continues to evolve, we’re preparing to unveil a new chapter in our journey, one that reflects our vision for the future and our commitment to helping customers solve increasingly complex formulation challenges.
While we can’t reveal the details just yet, visitors to our booth will be among the first to learn about several significant developments, including a major new partnership and the next evolution of SPI Pharma. These announcements represent exciting opportunities for our customers and partners and reinforce our commitment to innovation, collaboration, and growth.
Discover Their Latest Product Innovations
Over the past six months, SPI Pharma has continued to expand its portfolio with new solutions designed to help pharmaceutical and nutraceutical manufacturers accelerate development and enhance product performance. Meet with our experts to learn more about:
Lubripharm™ Pro SSF – Advanced lubrication technology designed to support tablet manufacturing efficiency and performance.
Valens™ QS-21 GH – Developed to support global health initiatives with innovative vaccine adjuvant technology.
Sorbitol Special FD (Fast Drying) – A new solution engineered to improve processing efficiency and manufacturing flexibility in softgel applications.
Stronger Together: SPI Pharma + ABITEC
We’re also proud to be sharing our booth with our sister company, ABITEC, highlighting the growing collaboration between our organizations.
Together, SPI Pharma and ABITEC bring complementary expertise across pharmaceutical excipients, lipid technologies, softgel solutions, and vaccine development. By combining our capabilities, we’re creating new opportunities to help customers overcome formulation challenges, accelerate innovation, and bring differentiated products to market more efficiently.
Be Among the First to See What’s Next
Visit our booth to explore our latest innovations, connect with our technical experts, and get a first look at the exciting developments shaping the future of SPI Pharma.
The future is taking shape, and we can’t wait to share it with you in Milan.
Vikram Thermo (India) Ltd. is a publicly listed leader in pharmaceutical excipients, known for innovative coating polymers and ready-to-use solutions. As India’s first EXCIPACT GMP-certified excipient manufacturer, we also hold US-DMF, ISO 9001, and HALAL certifications. Since 1985, our R&D-driven approach and world-class facilities have delivered high-quality products across 45+ countries, supporting global pharma with safe, reliable, and performance-focused solutions.
📍 Booth: 1D25, zone Excipients & Fine Chemicals
The Pharma Excipients Team will also participate at CPhI 2026 in Milan. Look forward to our videos and photos all around the newest developments in pharmaceutical excipients.
All4Nutra
